Trypsin inhibitors: promising candidate satietogenic proteins as complementary treatment for obesity and metabolic disorders?
The increase in non-communicable chronic diseases has aroused interest in the research of adjuvants to the classic forms of treatments. Obesity and metabolic syndrome are the main targets of confrontation because they relate directly to other chronic diseases. In this context, trypsin inhibitors,...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Outros Autores: | |
| Formato: | article |
| Idioma: | English |
| Publicado em: |
Taylor & Francis
|
| Assuntos: | |
| Endereço do item: | https://repositorio.ufrn.br/handle/123456789/54664 https://doi.org/10.1080/14756366.2018.1542387 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|